Blog
RSS FeedPosted by Michael Wonder on 07 Feb 2021
Modifying NICE’s approach to equity weighting
7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...
Posted by Michael Wonder on 30 Jan 2021
Vaccine distribution—equity left behind?
29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...
Posted by Michael Wonder on 15 Dec 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...
Posted by Michael Wonder on 03 Nov 2020
PHARMAC funding resources to focus on medicines access equity
3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...
Posted by Michael Wonder on 21 Oct 2020
Access to the latest and most effective diabetes drugs depends on where you live and what you earn
21 October 2020 - Access to the latest and most effective drugs for Australians with diabetes can depend on where ...
Posted by Michael Wonder on 20 Oct 2020
COVID-19 vaccines: time to talk about the uncertainties
20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...
Posted by Michael Wonder on 07 Oct 2020
Countries pledge nearly US$1 billion to support equitable access to COVID-19 vaccines
6 October 2020 - Gavi, the Vaccine Alliance has welcomed pledges made this week in support of the Gavi COVAX AMC, ...
Posted by Michael Wonder on 17 Sep 2020
Rare Disorders New Zealand supports Human Rights Commission case against PHARMAC
17 September 2020 - Rare Disorders New Zealand supports patient advocate Fiona Tolich’s Human Rights Commission case against PHARMAC for ...
Posted by Michael Wonder on 29 Jul 2020
A proposed lottery system to allocate scarce COVID-19 medications: promoting fairness and generating knowledge
28 July 2020 - On May 1, 2020, the US FDA issued an Emergency Use Authorization for the unapproved drug remdesivir ...
Posted by Michael Wonder on 28 Jul 2020
PHARMAC report: should rich people get subsidised medicine?
29 July 2020 - Should wealthy New Zealanders have access to subsidised medicines when they could be investing in better ...
Posted by Michael Wonder on 12 Jul 2020
Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers
3 July 2020 - The US has bought up almost all the world’s supply of the antiviral drug remdesivir in ...
Posted by Michael Wonder on 22 Jun 2020
It’s time to put fairness into focus
19 June 2020 - Medicines New Zealand is today launching a digitally-enabled public awareness platform Fairness in Focus. ...
Posted by Michael Wonder on 07 May 2020
The equitable distribution of COVID-19 therapeutics and vaccines
7 May 2020 - Scientists from across the globe are racing to develop effective vaccines and therapeutics for COVID-19. ...
Posted by Michael Wonder on 10 Jun 2019
The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?
10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication. ...
Posted by Michael Wonder on 10 Apr 2019
ALP cancer plan ‘divisive, inequitable’
11 April 2019 - Labor’s decision to prioritise fee relief for cancer patients is a departure from its previous policies ...